Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

sections

RPS board members: now is not the time for vanity

So the Royal Pharmaceutical Society (RPS) national pharmacy board elections are over for another year. Now begins one of the most important phase: the election of the president of the RPS.

This year, however, we are not looking for who will be most photogenic wearing the chain of office at the International Pharmaceutical Federation congress, or someone who believes it is “my turn”, or a career politician looking for a good job with a national body or big company afterwards. We need someone prepared to fight the corner for pharmacy in a cash-limited, hostile environment.

Since the mid-1990s there have been countless ‘pilot studies’ and local initiatives. There are awards ceremonies every year by pharmacy bodies, suppliers, trade organisations, etc. I have won some myself. But how much has our role changed? Every one of these initiatives is judged by its impact on patients but how many have been incorporated into daily practice? Despite this evidence, still we achieve less than a sentence in the government’s NHS ‘Five year forward view’ document. The new hierarchy must take us forward on this basis. The membership is as apathetic as ever, evidenced by a dreadfully low turnout for the recent elections.

The task ahead is blindingly obvious. The chicanery unearthed in the judicial review on the community pharmacy funding cuts in England is an absolute disgrace. The funding cuts do not just affect pharmacy owners, they affect everyone in community pharmacy, including locums and employees. Safe staffing levels and work-based stress are issues that are made worse by the cuts and the manner in which the Department of Health set about this dreadful business is a disgrace. It was condemned by the judge who made the ruling.

Therefore, the new RPS English Pharmacy Board must set about attacking this state of affairs. The time for cosy relationships ceased when the cuts were first announced in December 2015. The evidence of what we can do is in the public domain and the new board must seek to promote this with utmost vigour. Doing so will be the biggest step in encouraging new membership.

There are already anecdotal reports of pharmacies struggling to pay suppliers. Closures will start and accelerate as banks pull credit lines. RPS members will be harmed professionally and financially. To the board members: this is not a time for vanity or relying on past relationships. The members are watching you.

Tony Schofield

Newscastle-Upon-Tyne

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2017.20203034

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • BNF and British National Formulary for Children

    BNF and British National Formulary for Children

    Now available as a 1 year print subscription to both the BNF and British National Formulary for Children, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £138.50Buy now
  • BNF and British National Formulary for Children

    BNF and British National Formulary for Children

    Now available as a 2 year print subscription to both the BNF and British National Formulary for Children, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.

    £262.50Buy now
  • Stockley's Drug Interactions

    Stockley's Drug Interactions

    Now in its twelfth edition, Stockley’s Drug Interactions is still the most comprehensive and authoritative international source of drug interaction information.

    £240.00Buy now
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.